During the past decade, North Central Neurology Associates, PC conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Central Neurology Associates, PC" #1 sponsor was "Genzyme, a Sanofi Company" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Novartis" with 2 trials sponsored and "Opexa Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Central Neurology Associates, PC" #1 collaborator was "Bayer" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Mallinckrodt" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "North Central Neurology Associates, PC" are "Multiple Sclerosis" (8 trials), "Multiple Sclerosis, Relapsing-Remitting" (7 trials), "Central Neuropathic Pain" (1 trials), "Clinically Isolated Syndrome" (1 trials) and "Parkinson Disease Psychosis" (1 trials). Many other conditions were trialed in "North Central Neurology Associates, PC" in a lesser frequency.

Most popular intervention types in "North Central Neurology Associates, PC" are "Drug" (13 trials), "Biological" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cladribine Tablets" (2 trials), "Interferon beta-1a" (2 trials), "Ocrelizumab" (2 trials) and "13-PCV Booster" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Central Neurology Associates, PC" are 20 trials for "All" genders.

Currently, there are NaN active trials in "North Central Neurology Associates, PC". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in North Central Neurology Associates, PC, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in North Central Neurology Associates, PC, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".